ClonOrgan Biotechnology

Private

ChengduHealthcare & Life Scienceshttp://clonorgan.com/

Last Round

Series A

Extension

Sep 5, 2025

Total Funding Raised

$8.3M

Company Overview

ClonOrgan Biotechnology is a biotechnology company that specializes in the research and development of xenotransplantation technologies, including the breeding of gene-edited donor pigs for organ and tissue transplantation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

xenotransplantationgene-edited pigsorgan replacementCRISPRsomatic cell cloningpig-to-human transplantdesignated pathogen-freeDPFlow-immunogenicity biomaterialshuman disease modelsregenerative medicinebiotech R&Danimal biotechnologyorgan shortage solutions

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ClonOrgan Biotechnology Comps

Public and private peers based on sector, stage, and business model.

ClonOrgan Biotechnology comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ClonOrgan Biotechnology Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Sep 5, 2025
Series A Extension	Jul 4, 2024
Series A	Sep 2, 2021
Early Funding	Dec 1, 2020
Angel	Oct 1, 2018

View all Funding Rounds

ClonOrgan Biotechnology Investors

Notable investors and investment history

ClonOrgan Biotechnology investors
Investor	Rounds
Shenzhen Sangel Venture Capital	Angel
YuanBio Venture Capital	Series A Extension
Lightspeed China Partners	Series A Extension
Luminous Ventures	Series A Extension

View all Investors

ClonOrgan Biotechnology Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ClonOrgan Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ClonOrgan Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersChengdu

Year Founded2018

Last FundingSep 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.